Overuse of colposcopy service in Mexico;Sobreutilización del servicio de colposcopia en México

Ginecologia y Obstetricia de Mexico

Volumn 73, Issue 12, 2005, Pages 637-647

  Madrigal De La Campa, María De Los Ángeles ^a,d   Lazcano Ponce, Eduardo Cesar ^b   Infante Castañeda, Claudia ^c  

^a SEDENA   (Mexico)

^b INSP

^c UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

^d Secretaria de la Defensa Nacional   (Mexico)

Author keywords

Colposcopy; Follow up; Service use

Indexed keywords

ADULT; AGED; ARTICLE; COLPOSCOPY; CONTROLLED STUDY; FEMALE; FOLLOW UP; GYNECOLOGICAL EXAMINATION; HEALTH CARE UTILIZATION; HEALTH SERVICE; HUMAN; INTERVIEW; MAJOR CLINICAL STUDY; MEDICAL INFORMATION; MEXICO; UTERINE CERVIX CANCER; UTERINE CERVIX CYTOLOGY; BIOPSY; CROSSOVER PROCEDURE; DIFFERENTIAL DIAGNOSIS; ECONOMICS; EVALUATION; MULTIVARIATE ANALYSIS; PATHOLOGY; RISK FACTOR; UTERINE CERVIX; UTERINE CERVIX DYSPLASIA; UTERINE CERVIX TUMOR; UTILIZATION REVIEW; VAGINA SMEAR;

ADULT; BIOPSY; CERVIX UTERI; COLPOSCOPY; CROSS-OVER STUDIES; DIAGNOSIS, DIFFERENTIAL; FEMALE; FOLLOW-UP STUDIES; HEALTH SERVICES MISUSE; HUMANS; INTERVIEWS; MEXICO; MULTIVARIATE ANALYSIS; RISK FACTORS; UTERINE CERVICAL DYSPLASIA; UTERINE CERVICAL NEOPLASMS; VAGINAL SMEARS;

EID: 33645868977     PISSN: 03009041     EISSN: 03009041     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Walboomers JM, Jacobs MV, Manos MM, Bosch FX, Kummer JA, Shah KV, et al. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol 1999;189:12-19.
2. Koss LG. Cytology: accuracy of diagnosis. Cancer 1989;64:249-57.
3. Bosh FX, Manos MM, Muñoz N, Sherman M, Cansen AM, Peto J, et al. Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. International Biological Study on Cervical Cancer (IBSCC) Study Group. J Natl Cancer Inst 1995;87:796-802.
4. Logros de la Campaña Nacional contra el Cáncer (editorial). Salud Publica Mex 1976;13(2):5-6.
5. Miller AB. Cervical cancer screening programs. World Health Organization. Geneva, 1992.
6. Aristizabal N, Cuello C, Correa P. The impact of vaginal cytology on cervical cancer risks in Cali, Colombia. Int J Cancer 1984;34:5-9.
7. Lazcano E, Moss S, Cruz A, Alonso P, Casares Q, Martínez de León C, et al. Factores que determinan la participación en el tamizaje de cáncer cervical en el estado de Morelos. Salud Publica Mex 1999;41:278-85.
8. Wespi HJ. 50 years of colposcopy. Ann Ostet Ginecol Med Perinat 1976;2:109-319.
9. Benedet J, Anderson G, Matisic JP. A quality-control program for colposcopy practice. Obstet Gynecol 1991;78:872-5.
10. Davey D, Armenti C. HPV primary screening for cervical cancer: more pain than protection. Diagn Cytopathol 2000;22:333-5.
11. Sanders G, Craddock C. Factors influencing default at a hospital colposcopy clinic. Qual Health Care 1992;4:236-40.
12. Arillo E, Lazcano E, Salazar M, Salmerón J, Alonso P. El conocimiento de profesionales de salud sobre la prevención de cáncer cervical. Alternativas de educación médica. Salud Publica Mex 2000;42:34-41.
13. Kavanagh A, Simpson J. Predicting nonattendance for colposcopy clinic follow-up after referral for an abnormal Pap smear. Aust NZ J Public Health 1996;20(3):266-71.
14. Shylasree T, Ashraf M, Jayawickrama N. Retrospective audit of standards and quality in colposcopy services in a district hospital. J Qual Clin Pract 2001;21(1-2):22-24.
15. Funke BL, Nicholson ME. Factors affecting patient compliance among women with abnormal Pap smears. Patient Educ Couns 1993;20:5-15.
16. Gath DH, Halam M. Emotional reactions in women attending a UK colposcopy clinic. J Epidemiol Community Health 1995;49:79-83.
17. Lazcano E, Moss S, Cruz A, Alonso P, et al. Factores que determinan la participación en el tamizaje de cáncer cervical en el estado de Morelos. Salud Publica Mex 1999;41:278-85.
18. Kinlen LJ, Spriggs AL. Women with positive cervical smears but without surgical intervention. A follow-up study. Lancet 1978;2:463-5.
19. Ellman R. Problems of follow-up for abnormal cervical smears. Discussion paper. J R Soc Med 1990;83:94-95.
20. Paskett ED, Phillips KC, Miller ME. Improving compliance among women with abnormal Papanicolaou smears. Obstet Gynecol 1995;86:353-9.
21. Lerman C, Hanjani P, Caputo C, et al. Telephone counseling improves adherence to colposcopy among lower-income minority women. J Clin Oncol 1992;10:330-3.
22. Campion MJ, Brown JR, Mc Chance DJ, et al. Psychological side-effects of the mass screening on cervical cancer. Br J Obstet Gynaecol 1988;95:175-81.
23. Eardley A, Elkind AK, Spencer B, Hobbs P, Pendleton LL, Haran D. Attendance for cervical cancer screening-whose problem? Soc Sci Med 1985;20:955-62.
24. Luke K. Cervical cancer screening: meeting the needs of minority ethnic women. Br J Cancer 1996;74(Suppl XXIX):S47-S50.
25. Sherlaw-Johnson, Gavillan S, Jenkins D. Withdrawing low risk women from cervical screening programmes: mathematical modeling study. BMJ 1999;318:356-61.
26. Teale G, Moffitt D, Mann C, Luesley D. Management guidelines for women with normal colposcopy after low-grade cervical abnormalities: population study. BMJ 2000;320:1693-6.